Pulling SEC filings + quote and writing the call…
Genvor Inc
Next earnings ≈ Aug 11, 2026 · est. from filing cadence
High return on equity (425.9%).
Revenue (FY2021) $0.00 · FY2021
Genvor Inc shows $0.00 in FY2021 revenue, and 425.9% ROE.
Supporting the case: high return on equity (425.9%); conservative balance sheet (liabilities/equity -1.03x).
Is GNVR a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY20 | FY21 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | -$3.10M | -$1.44M | -$2.78M | -$6.41M |
| Net income | -$4.87K | -$3.44M | -$1.71M | -$2.88M | -$5.59M |
| Diluted EPS | — | — | -$0.09 | -$0.15 | -$0.22 |
| Net margin | — | — | — | — | — |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001792941, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 9:46:05 PM.
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 22, 2026, 5:46 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-04-15 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 250K @ $0.50 | $125K |
| 2026-04-07 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 250K | |
| 2026-01-09 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 250K | |
| 2025-12-02 | Jaynes Jessee M Chief Research Officer | Award | 124K @ $1.50 | $186K |
| 2025-10-08 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 250K | |
| 2025-07-01 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 250K | |
| 2025-05-08 | Jaynes Jessee M Chief Research Officer | Award | 400K @ $0.25 | $100K |
| 2025-05-08 | Yates Clayton Clopton Director | Award | 400K @ $0.25 | $100K |
| 2025-05-02 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 500K @ $0.25 | $125K |
| 2024-04-25 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 25.0K | |
| 2024-04-25 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 4.88M | |
| 2024-04-17 | Pawlak Chad Lee Sr. Chief Executive Officer | Award | 25.0K |
1195 tracked peers · median